Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

4.5K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.5K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

819
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
819

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Is the future of cardiac repair cell-free?

European heart journal·2026
Same author

Targeting RUNX1 protects against diastolic dysfunction in a two-hit mouse model of heart failure with preserved ejection fraction.

Cardiovascular research·2026
Same author

Mechanical load inhibits cancer growth in mouse and human hearts.

Science (New York, N.Y.)·2026
Same author

<i>CLIPPER</i> Regulates LPIN1-Mediated Mitochondrial Biogenesis and Heart Regeneration.

Circulation research·2026
Same author

<i>Zeb2os</i> Hinders Cardiac Healing by Suppressing ZEB2 Reactivation and Cardiomyocyte Dedifferentiation.

Circulation research·2026
Same author

Racial diversity in cannabis use disorder research: A systematic review.

Drug and alcohol dependence·2025

Related Experiment Video

Updated: Dec 25, 2025

Delivery of Modified mRNA in a Myocardial Infarction Mouse Model
06:03

Delivery of Modified mRNA in a Myocardial Infarction Mouse Model

Published on: June 11, 2020

9.6K

Non-coding RNA therapeutics for cardiac regeneration.

Luca Braga1, Hashim Ali1, Ilaria Secco1

  • 1British Heart Foundation Centre of Research Excellence, School of Cardiovascular Medicine & Sciences, King's College London, The James Black Centre, 125 Coldharbour Lane, London SE5 9NU, UK.

Cardiovascular Research
|March 28, 2020
PubMed
Summary

Non-coding RNAs (ncRNAs) regulate cardiomyocyte replication for cardiac regeneration after heart attack. Therapeutic strategies using ncRNAs show promise for heart repair, but require further safety and efficacy studies in large mammals.

Keywords:
NanoparticleAAV vectorsCardiomyocyteGene therapyHeartInfarctionMicroRNARegenerationYAPlncRNA

More Related Videos

Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes
09:16

Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes

Published on: June 3, 2018

7.6K
Isolation, Transfection, and Long-Term Culture of Adult Mouse and Rat Cardiomyocytes
09:17

Isolation, Transfection, and Long-Term Culture of Adult Mouse and Rat Cardiomyocytes

Published on: October 10, 2020

9.9K

Related Experiment Videos

Last Updated: Dec 25, 2025

Delivery of Modified mRNA in a Myocardial Infarction Mouse Model
06:03

Delivery of Modified mRNA in a Myocardial Infarction Mouse Model

Published on: June 11, 2020

9.6K
Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes
09:16

Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes

Published on: June 3, 2018

7.6K
Isolation, Transfection, and Long-Term Culture of Adult Mouse and Rat Cardiomyocytes
09:17

Isolation, Transfection, and Long-Term Culture of Adult Mouse and Rat Cardiomyocytes

Published on: October 10, 2020

9.9K

Area of Science:

  • Cardiovascular Biology
  • Molecular Medicine
  • RNA Therapeutics

Background:

  • Myocardial infarction impairs heart function by limiting cardiomyocyte replication.
  • Non-coding RNAs (ncRNAs), including microRNAs (miRNAs) and long non-coding RNAs (lncRNAs), are key regulators of cardiomyocyte proliferation.
  • Specific ncRNAs can either promote or inhibit cardiomyocyte cell cycle activity.

Purpose of the Study:

  • To review the role of ncRNAs in regulating cardiomyocyte proliferation and cardiac regeneration.
  • To explore the therapeutic potential of ncRNAs for stimulating cardiac repair after myocardial infarction.

Main Methods:

  • Literature review of studies on ncRNAs and cardiac regeneration.
  • Analysis of miRNA clusters (e.g., miR-302∼367, miR-17∼92) and individual miRNAs (e.g., miR-199a-3p, miR-590-3p, let-7, miR-15).
  • Discussion of therapeutic delivery methods for ncRNA-based treatments, including gene therapy and small nucleic acid therapeutics.

Main Results:

  • Certain miRNAs (e.g., miR-302∼367 cluster) promote cardiomyocyte proliferation, while others (e.g., let-7, miR-15 families) suppress it.
  • Long non-coding RNAs also influence cardiomyocyte proliferation.
  • ncRNAs offer potential therapeutic targets for enhancing cardiac regeneration.

Conclusions:

  • ncRNAs represent a promising avenue for therapeutic cardiac regeneration.
  • Strategies involve using ncRNAs to stimulate cardiomyocyte replication or inhibit suppressors.
  • Further research in large mammals is crucial to ensure safety and efficacy before clinical application.